| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,037 |
2,661 |
$234K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,416 |
2,937 |
$166K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
842 |
645 |
$64K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
324 |
287 |
$45K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
512 |
449 |
$38K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
459 |
350 |
$31K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
279 |
225 |
$23K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
425 |
303 |
$15K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
590 |
538 |
$14K |
| 96127 |
|
667 |
564 |
$11K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
620 |
522 |
$10K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
391 |
226 |
$8K |
| 96160 |
|
429 |
340 |
$6K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
148 |
92 |
$6K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
15 |
15 |
$5K |
| 92551 |
|
237 |
196 |
$4K |
| 90686 |
|
390 |
335 |
$4K |
| 90670 |
|
210 |
142 |
$3K |
| D1206 |
Topical application of fluoride varnish |
98 |
82 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
152 |
147 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
52 |
43 |
$2K |
| 90698 |
|
170 |
125 |
$2K |
| 90674 |
|
87 |
81 |
$1K |
| 85018 |
|
429 |
362 |
$993.81 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
42 |
37 |
$613.20 |
| 90700 |
|
42 |
28 |
$598.07 |
| 90661 |
|
35 |
35 |
$584.85 |
| 83655 |
|
43 |
37 |
$509.98 |
| 90633 |
|
32 |
24 |
$501.52 |
| 99173 |
|
65 |
48 |
$484.25 |
| 90651 |
|
30 |
13 |
$463.95 |
| 36416 |
|
112 |
101 |
$463.30 |
| 90619 |
|
29 |
12 |
$447.24 |
| 99174 |
|
58 |
53 |
$432.10 |
| 90734 |
|
39 |
27 |
$428.80 |
| 90744 |
|
22 |
15 |
$338.57 |
| 90680 |
|
22 |
13 |
$245.52 |